📋 Product Overview Table

🌐 Specification	🧾 Details
💊 Active Ingredient	Cabergoline 0.5mg
🧪 Formulation	Dopamine Agonist Tablet
🏭 Manufacturer	Sun Pharmaceutical Industries Ltd
💊 Dosage Form	Oral Tablet
📦 Packaging	4 Tablets in 1 Strip
🩺 Indication	Hyperprolactinemia, pituitary tumors, Parkinson’s disease (off-label)
🇺🇸 US Brand Equivalent	Dostinex (by Pfizer)
⏱️ Delivery Time	6 to 15 days

🧬 Introduction – What is Cabgolin 0.5mg (Cabergoline)?

Cabgolin 0.5mg is a high-strength dopamine D2 receptor agonist formulated with Cabergoline, prescribed for managing hyperprolactinemia—a condition involving elevated levels of prolactin hormone in the blood. This hormonal imbalance can lead to irregular menstruation, infertility, galactorrhea, and sexual dysfunction in both men and women.

Produced by Sun Pharmaceutical Industries Ltd, a globally respected Indian pharmaceutical company, Cabgolin 0.5mg offers a cost-effective and reliable alternative to Dostinex, a widely used branded formulation. Its longer half-life and improved patient compliance make it ideal for those who require less frequent dosing.

Cabgolin is also used in reducing the size of pituitary adenomas, improving ovulatory function, and even as off-label support in early-stage Parkinson’s disease or dopamine deficiency disorders. Due to its high potency, Cabgolin 0.5mg is typically introduced once a patient has shown good tolerance to the 0.25mg strength or has progressed in their treatment protocol.

By mimicking dopamine’s action in the brain, Cabgolin suppresses prolactin release from the anterior pituitary, thereby restoring endocrine balance and supporting reproductive health.

🎥 Video Overview – Cabergoline: Hormonal Reset in Focus

📺 “Cabgolin 0.5mg Explained: How It Treats Prolactin Excess“

🎬 Video Placeholder – Covers mechanism of action, dosing, expected outcomes, and tips for tolerability.

Patients should always take Cabgolin 0.5mg under guidance from an endocrinologist or gynecologist.

🔬 Pharmacological Profile

🧪 Parameter	📊 Details
Drug Class	Dopamine D2 Receptor Agonist
Mechanism	Suppresses prolactin from pituitary gland
Bioavailability	Approx. 60%
Onset of Action	Within 3 hours
Elimination Half-Life	~63–69 hours
Metabolism	Primarily hepatic
Excretion	Fecal and renal pathways

💡 Dosing Guidelines

🗓️ Condition	💊 Typical Dose
Hyperprolactinemia	0.5mg once or twice weekly, titrated up as needed
Prolactinomas	Up to 1mg twice weekly (under medical supervision)
Parkinson’s Disease (off-label)	0.5mg–3mg/day (individualized therapy)

Always begin at the lowest dose to reduce side effects and gradually increase as advised.

⚠️ Side Effects & Precautions

💥 Common Side Effects	❗ Serious Side Effects (Rare)
Dizziness, headache	Cardiac valve fibrosis, pulmonary complications
Nausea, mild hypotension	Impulse control issues, hallucinations
Constipation, nasal stuffiness	Orthostatic hypotension

Cautions:

Avoid alcohol consumption
Monitor blood pressure regularly
Contraindicated in patients with heart valve disease or fibrotic disorders

🧃 Storage Guidelines

Store below 25°C (77°F)
Keep the tablets in the original package
Protect from heat, light, and moisture

🌍 Global Availability & Import Guide

🌎 Country	📦 Import Status	📋 Prescription Requirement
🇺🇸 USA	FDA personal import allowed	Yes
🇬🇧 UK	Permitted via MHRA personal use policy	Yes
🇦🇺 Australia	Allowed under TGA personal use rules	Yes

🔗 Related Medications

💊 Product Name	🏭 Manufacturer	📖 Description
Cabgolin 0.25mg	Sun Pharma	Lower strength option for gradual dose escalation
Dostinex 0.5mg	Pfizer Inc.	Original brand-name Cabergoline for prolactin imbalance
Bromopil 2.5mg	Intas Pharma	Bromocriptine alternative for dopamine agonist therapy
Cabermax 0.5mg	Johnlee Pharma	Budget-friendly Cabergoline alternative
Proctinal 2.5mg	GSK	Popular bromocriptine used in prolactin and fertility disorders

📚 Medical References

🩺 Doctor’s Opinion – Dr. Vikram Shetty, DM (Endocrinology)

“Cabgolin 0.5mg is an effective formulation for patients requiring stronger prolactin suppression. Its weekly dosing and tolerability make it my go-to choice in long-term endocrine management plans.”